We herein report the first case of pulmonary metastasis with lepidic growth that originated from cholangiocarcinoma. A 77-year-old man was admitted to our hospital due to exertional dyspnea and liver dysfunction. Computed tomography showed widespread infiltration and a ground-glass opacity in the lung and dilation of the intrahepatic bile duct. The pulmonary lesion progressed rapidly, and the patient died of respiratory failure. Cholangiocarcinoma and lepidic pulmonary metastasis were pathologically diagnosed by an autopsy. Lepidic pulmonary growth is an atypical pattern of metastasis, and immunopathological staining is useful to distinguish pulmonary metastasis from extrapulmonary cancer and primary pulmonary adenocarcinoma.
Introduction
The lung is a common site for metastasis. Multiple nodules or lymphangitic carcinomatosis are observed in the majority of cases of metastatic lung tumors (1) (2) (3) . However, pulmonary metastasis sometimes presents uncommon radiographic features, making it difficult to distinguish the metastasis from primary lung cancer and other benign pulmonary diseases. These features include cavitation, calcification, hemorrhaging around metastatic nodules, pneumothorax, an air-space pattern, tumor embolism, endobronchial metastasis, dilated vessels within a mass, and sterilized metastasis (4) . Of these radiographic features, an air-space pattern can occur when the tumor progresses along the alveolar wall, which is known as lepidic growth. Although lepidic tumor growth is typically observed in primary pulmonary adenocarcinoma, some reports have described cases of metastatic pulmonary adenocarcinoma from extrapulmonary organs, such as the gallbladder, pancreas, stomach, colon, and breast (5-7).
We herein report an autopsy case of lepidic pulmonary metastasis from cholangiocarcinoma, which was observed as a pulmonary air-space consolidation and ground-glass opacity on chest computed tomography (CT). To the best of our knowledge, this is the first case of lepidic pulmonary metastasis from cholangiocarcinoma. A B oxygen saturation of the peripheral artery was degraded to 94% at room air, and the patient was afebrile. Pulmonary CT revealed a widespread air-space consolidations and ground-glass opacities (Fig. 1B) . A honeycomb change was also observed, mainly in the left lower lobe. This change had been previously observed on a CT scan conducted 6 months prior to the patient's first visit, suggesting that he had subclinical interstitial pneumonia. Laboratory data on admission are presented in Table and  revealed According to these findings, we initially treated the patient as having pneumocystis pneumonia and/or acute exacerbation of pre-existing interstitial pneumonia using corticosteroid and sulfamethoxazole/trimethoprim (SMX/TMP). SMX/TMP was discontinued since the elevated (1,3)-β-Dglucan level was due to a false positive result. Despite these intensive treatments, the lung infiltrates progressively expanded ( Fig. 2) .
Although primary lung cancer was suspected due to the pattern of the infiltrates, best supportive care for putative lung cancer was provided because the performance status of this patient had degraded rapidly. He died of respiratory failure 3 months after admission.
An autopsy was subsequently performed. In the hepatic hilus, 15 mm of solid mass was observed around the root of the left hepatic duct. Microscopically, atypical cells grew along the surface of the intrahepatic bile duct (Fig. 3A) and showed stromal invasion forming irregular tubular structures with or without papillary projection ( Fig. 3B and C) . Exfoliation of tumor clusters was evident in the lumens (Fig. 3C) . The tumor showed positivity for cytokeratin 7 (CK7; Fig. 3D ) and cytokeratin 20 (CK20; Fig. 3E ) on immunostaining. These findings suggested a diagnosis of cholangiocarcinoma, as had been previously suspected. Adenocarcinoma was also observed in the bilateral pulmonary lobes. Atypical cells were observed along the alveolar wall in most pulmonary areas ( Fig. 4A and B) . In resemblance with a liver tumor, stromal invasion of the carcinoma forming irregular tubular structures with or without papillary projection ( Fig. 4C and D) was also found in the lung specimen. Additionally, a large number of tumor clusters were found in the alveolar cavity, suggesting transbronchial spread of adenocarcinoma (Fig. 4B ). Although these findings were similar to those of primary pulmonary adenocarci- noma, the tumor tissues that were observed in the lung specimen were morphologically very similar to cholangiocarcinoma that had been found in this patient. Furthermore, in resemblance with the liver specimen, both CK7 and CK20 were positive on immunostaining ( Fig. 4E and F) .
A B
Immunostaining with thyroid transcription factor-1 (TTF-1; Fig. 4G ) and Napsin-A (Fig. 4H) were additionally performed, both of which were negative in the pulmonary cancer lesion. Periodic acid-Schiff (PAS) staining showed that the tumors found in the liver and lung were rich in mucin production ( Fig. 5A and E) , and both tumors showed negativity for mucin2 (MUC2; Fig. 5B and F) , focal positivity for mucin5Ac (MUC5Ac; Fig. 5C and G), and focal positivity for mucin6 (MUC6; Fig. 5D and H) upon immunostaining.
No evidence supported the existence of an active fungal infection, including Pneumocystis jirovecii, in the lung specimen.
According to these histopathological findings, we finally diagnosed the patient with lepidic pulmonary metastasis from cholangiocarcinoma.
Discussion
Lepidic growth of cancer cells is a common pathological feature of primary pulmonary adenocarcinoma. However, pulmonary metastasis can also show lepidic growth, although it is rare. The lepidic growth of metastatic cancer is associated with radiological findings such as air-space nodules, consolidation containing an air bronchogram, focal or extensive ground-glass opacities, and nodules with halo signs (4). These radiological features of lepidic metastasis also resemble those of primary pulmonary adenocarcinoma that shows lepidic growth. Some case reports have described lepidic pulmonary metastasis from adenocarcinoma of extra-thoracic organs, such as of the gallbladder, pancreas, stomach, colon, and breast (5) (6) (7) (8) . In addition to the pulmonary metastasis of adenocarcinoma, the pulmonary metastasis of malignant melanoma can also show pathologically lepidic growth in the lung (9) . In a previous case series, approximately 10% of cases with an air-space pattern on a chest CT scan were identified as metastatic adenocarcinomas. However, that series only included 1 case in which pancreatic carcinoma was pathologically shown to have undergone lepidic pulmonary metastasis (8) .
In the present case, metastatic lung cancer from cholangiocarcinoma was strongly suspected because the pathological features observed in the lung tumor were closely related to those observed in the bile duct tumors. For the purpose of further examination, several immunostainings were performed. Immunostaining with CK7 and CK20 is commonly used to estimate the origin of carcinoma. A previous report has demonstrated that 90% of pulmonary adenocarcinomas show a CK7 + /CK20
-pattern, whereas 43% of cholangiocarcinoma show a CK7 + /CK20 + pattern (10) . Furthermore, TTF- 1 and Napsin-A have been reported to show high rates of positivity (73% and 83%, respectively) (11) in primary pulmonary adenocarcinoma. According to these data, metastasis from cholangiocarcinoma is more compatible for the diagnosis of the present patient than primary lung cancer because immunostaining of the lung tumor showed the CK7 + /CK20 + pattern, as well as negativity for TTF-1 and Napsin-A. The similarities in the MUC2, MUC5Ac, and MUC6 expression also support this diagnosis. To the best of our knowledge, the present report is the first to describe a case of lepidic pulmonary metastasis from cholangiocarcinoma. Similar to some previous cases (7, 9) , lepidic pulmonary metastasis progressed rapidly in the present case, which might be partially explained by rapid intrabronchial tumor transition. Indeed, pathologically, many tumor clusters were observed in the alveolar space of the patient's lung specimen. In cases of bronchioloalveolar carcinoma, aerogenous tumor spread is known to indicate a poor prognosis (12) . Additionally, in cases of pulmonary metastasis, a rapid progression may be implied by the histopathologic features of exfoliations of tumor clusters in the alveolar space.
In conclusion, we presented a case of rapidly progressed lepidic pulmonary metastasis from cholangiocarcinoma. Radiological and histopathological features of lepidic pulmonary metastasis may resemble those of primary adenocarcinoma. A pathological differential diagnosis should thus be performed early and include immunostaining.
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